drugset / Trial / NCT00832650

Multiple Dose Study To Investigate The Effects Of Fesoterodine And Solifenacin On Gastrointestinal Transit

NCT00832650

Phase 1 Terminated 60 enrolled Pfizer
RandomizedParallel-groupTriple-blindTreatment

Summary

To assess the effect of fesoterodine 8 mg as compared to solifenacin 10 mg on colonic transit.

Timeline

Start
2009-04
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fesoterodine Other / unclassified 8 mg
Comparator Solifenacin Small molecule 10 mg

Indications

No indication recorded.